Skip to content

MOSAIC® 305C229 (UDI 00643169594722)Recalls & reported problems

Medtronic, Inc. · VLV 305C229 MOSAIC AOR CII US PEEK · Class 3 · Implant

All models of MOSAIC (59)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
6
Deaths reported
0
Injuries reported
6
Recalls naming it
0

Summary

The FDA's MAUDE database contains 6 adverse event reports that list this exact device (DI 00643169594722), received between Oct 27, 2017 and Dec 17, 2025 — classified as 6 injuries.

The most frequently reported specific device problem is “Insufficient Device Problem Information” (2 reports).

3 other recalls cover devices cleared under the same FDA submission (P990064); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 1 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 1 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 1 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem2
  • Insufficient Device Problem Information2
  • Intravalvular regurgitation1
  • Patient Device Interaction Problem1
  • Perivalvular Leak1

Patient problems

  • Insufficient Information2
  • Aortic Valve Insufficiency/ Regurgitation1
  • Arrhythmia1
  • Blood Loss1
  • Dyspnea1
  • Hemolytic Anemia1
  • Hemorrhage/Blood Loss/Bleeding1
  • Insufficiency, Valvular1

Recent adverse event reports

The 6 most recent of 6 reports, in the reporter's own words as published by the FDA.

  • InjuryDec 17, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT 1 DAY POST IMPLANT OF THIS 29MM AORTIC BIOPROSTHETIC VALVE, IT WAS EXPLANTED AND REPLACED WITH A 27MM AORTIC BIOPROSTHETIC VALVE OF THE SAME MODEL. THE REASON FOR THE REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Insufficient Information

    MAUDE report 23826034 ↗
  • InjuryMay 22, 2025Insufficient Device Problem Information; Intravalvular regurgitation; Insufficient Device Problem Information; Intravalvular regurgitation

    ADDITIONAL INFORMATION RECEIVED REPORTED THE REASON FOR INTERVENTION AS SEVERE REGURGITATION. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Aortic Valve Insufficiency/ Regurgitation; Insufficient Information

    MAUDE report 22073116 ↗
  • InjuryMay 13, 2024Patient Device Interaction Problem; Patient Device Interaction Problem

    MEDTRONIC RECEIVED INFORMATION THAT POST IMPLANT OF THIS 29MM AORTIC BIOPROSTHETIC VALVE, ON THE SAME DAY THE PATIENT EXPERIENCED UNSPECIFIED HEART RHYTHM CHANGES, THE FOLLOWING DAY THE PATIENT EXPERIENCED PAINFUL BREATHING WITH DYSPNEA AT REST, AN ELECTROCARDIOGRAM (EKG) WAS PERFORMED: SINUS RHYTHM WITH ATRIOVENTRICULAR (AV) DISSOCIATION, AND WIDE QRS RHYTHM WITH OCCASIONAL PREMATURE VENTRICULAR COMPLEXES (PVCS) WERE NOTED. AT THE TIME THE PATIENT "DENIES PAIN, BUT WITH TRANSFER PAIN INCREASED FROM 0-10 ... PATIENT EXPERIENCED INCREASED PAIN WITH ACTIVITY AND DEMONSTRATES SHORT SHALLOW BREATHING DUE TO PAIN... PATIENT IS REFUSING NARCOTIC PAIN MEDS." MEDICATIONS WERE GIVEN, NO SURGICAL INTERVENTION OR ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Arrhythmia; Dyspnea

    MAUDE report 19297929 ↗
  • InjuryJan 22, 2020Perivalvular Leak; Perivalvular Leak

    MEDTRONIC RECEIVED INFORMATION THAT 2 MONTHS AND 12 DAYS POST IMPLANT OF THIS 29MM BIOPROSTHETIC AORTIC VALVE, IT WAS EXPLANTED AND REPLACED WITH A BIOPROSTHETIC VALVE OF THE SAME SIZE AND MODEL DUE TO PARAVALVULAR LEAK (PVL). NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Insufficiency, Valvular

    MAUDE report 9616519 ↗
  • InjuryFeb 19, 2018Insufficient Device Problem Information; Insufficient Device Problem Information

    MEDTRONIC RECEIVED INFORMATION THAT IMMEDIATELY POST IMPLANT OF THIS AORTIC BIOPROSTHETIC VALVE, THE VALVE WAS EXPLANTED AND REPLACED WITH AN UNKNOWN DEVICE. THE REASON FOR THE REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: No Information

    MAUDE report 7280608 ↗
  • InjuryOct 27, 2017Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    MEDTRONIC RECEIVED INFORMATION THAT THE SAME DAY POST IMPLANT OF THIS AORTIC BIOPROSTHETIC VALVE, THE PATIENT PRESENTED WITH AN INTRATHORACIC BLEED WHICH REQUIRED THE PATIENT TO GO BACK INTO THE OPERATING ROOM FOR SURGICAL EXPLORATION. EXPLORATION OF THE SURGICAL SITE NOTED THAT THE SOURCE OF THE BLEED COULD NOT BE DETERMINED. THE PATIENT RECEIVED 3 UNITS OF PACKED RED BLOOD CELLS, 3 UNITS OF PLATELETS AND 2 UNITS OF FRESH FROZEN PLASMA. MEDICATION WAS GIVEN TO THE PATIENT AND THE ISSUE WAS RESOLVED THE FOLLOWING DAY. THE DEVICE REMAINS IMPLANTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Blood Loss; Hemolytic Anemia; Hemorrhage/Blood Loss/Bleeding

    MAUDE report 6984451 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under P990064. One submission often covers many models, so check the product and lot details in each record.

  • Z-1880-2019 · May 21, 2019 · Terminated
    Mosaic 310 Bioprosthesis, Mitral, REF 310C29 - Product Usage: Replacement of malfunctioning native or prosthetic aortic and/or mitral valves.
  • Z-1881-2019 · May 21, 2019 · Terminated
    Mosaic 310 Bioprosthesis, Mitral, REF 310C31 - Product Usage: Replacement of malfunctioning native or prosthetic aortic and/or mitral valves.
  • Z-1225-2009 · Jan 26, 2009 · Terminated
    Medtronic Mosaic Porcine Bioprostheses with Cinch, Heart Valve; Model 305; Catalog #s 305C21AA, 305C2701, 305C2301, 305C2501, and 305C2901; Sterile LC; Rx only; Medtronic Inc 710 M

Other heart-valve, non-allograft tissue devices

All heart-valve, non-allograft tissue devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page